These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Effects of long-term erythropoietin therapy on fibrinolytic system in haemodialyzed patients. Pawlak K; Pawlak D; Mysliwiec M Thromb Res; 2008; 121(6):787-91. PubMed ID: 17869326 [TBL] [Abstract][Full Text] [Related]
24. Plasma fibrinolytic activity in patients undergoing major abdominal surgery. Mellbring G; Dahlgren S; Wiman B Acta Chir Scand; 1985; 151(2):109-14. PubMed ID: 3873768 [TBL] [Abstract][Full Text] [Related]
25. Plasminogen activators (t-PA and u-PA) and plasminogen activators inhibitors (PAI-1 and PAI-2) in some myeloproliferative syndromes. Rość D; Kremplewska-Nalezyta E; Gadomska G; Zastawna E; Michalski A; Drewniak W Med Sci Monit; 2000; 6(4):684-91. PubMed ID: 11208392 [TBL] [Abstract][Full Text] [Related]
26. Sex differences in the determinants of fibrinolytic activity. MacCallum PK; Cooper JA; Howarth DJ; Meade TW; Miller GJ Thromb Haemost; 1998 Mar; 79(3):587-90. PubMed ID: 9531046 [TBL] [Abstract][Full Text] [Related]
27. Vascular and fibrinolytic effects of intra-arterial tumour necrosis factor-alpha in patients with coronary heart disease. Robinson SD; Dawson P; Ludlam CA; Boon NA; Newby DE Clin Sci (Lond); 2006 Mar; 110(3):353-60. PubMed ID: 16309383 [TBL] [Abstract][Full Text] [Related]
28. Laboratory evidence of hyperfibrinolysis in association with low plasminogen activator inhibitor type 1 activity. Agren A; Wiman B; Schulman S Blood Coagul Fibrinolysis; 2007 Oct; 18(7):657-60. PubMed ID: 17890953 [TBL] [Abstract][Full Text] [Related]
29. Fibrinolytic response to exercise in women using third-generation oral contraceptives. Weiss C; Walter B; Dorsch MF; Bärtsch P Blood Coagul Fibrinolysis; 2006 Oct; 17(7):563-8. PubMed ID: 16988552 [TBL] [Abstract][Full Text] [Related]
30. [Selected new atherosclerosis risk factors and markers of fibrinolysis in children and adolescents with obesity, hypertension and diabetes]. Głowińska B; Urban M; Koput A; Galar M Przegl Lek; 2003; 60(1):12-7. PubMed ID: 12884639 [TBL] [Abstract][Full Text] [Related]
31. Sex differences in coagulation and fibrinolysis in subjects with coronary artery disease. Ossei-Gerning N; Wilson IJ; Grant PJ Thromb Haemost; 1998 Apr; 79(4):736-40. PubMed ID: 9569183 [TBL] [Abstract][Full Text] [Related]
33. Relationship of tissue plasminogen activator, plasminogen activator inhibitor-1 and fibrinogen with coronary artery disease in South Indian male subjects. Deepa R; Velmurugan K; Saravanan G; Dwarakanath V; Agarwal S; Mohan V J Assoc Physicians India; 2002 Jul; 50():901-6. PubMed ID: 12126344 [TBL] [Abstract][Full Text] [Related]
34. Excess soluble urokinase-type plasminogen activator receptor in the plasma of dialysis patients correlates with increased fibrinolytic activity. Pawlak K; Pawlak D; Mysliwiec M Thromb Res; 2007; 119(4):475-80. PubMed ID: 16828495 [TBL] [Abstract][Full Text] [Related]
35. Oxidative stress effects fibrinolytic system in dialysis uraemic patients. Pawlak K; Pawlak D; Mysliwiec M Thromb Res; 2006; 117(5):517-22. PubMed ID: 15964061 [TBL] [Abstract][Full Text] [Related]
36. Plasminogen and plasmin activity in patients with coronary artery disease. Drinane MC; Sherman JA; Hall AE; Simons M; Mulligan-Kehoe MJ J Thromb Haemost; 2006 Jun; 4(6):1288-95. PubMed ID: 16706973 [TBL] [Abstract][Full Text] [Related]
37. Relation of the prothrombotic state to increasing age (from the Framingham Offspring Study). Tofler GH; Massaro J; Levy D; Mittleman M; Sutherland P; Lipinska I; Muller JE; D'Agostino RB Am J Cardiol; 2005 Nov; 96(9):1280-3. PubMed ID: 16253598 [TBL] [Abstract][Full Text] [Related]
38. Fibrinolytic activity in peripheral atherosclerosis in the elderly. van der Bom JG; Bots ML; Haverkate F; Meyer P; Hofman A; Grobbee DE; Kluft C Thromb Haemost; 1999 Feb; 81(2):275-80. PubMed ID: 10064006 [TBL] [Abstract][Full Text] [Related]
39. Systemic and translesional activation of coagulation, fibrinolytic, and inhibitory systems in candidates for coronary angioplasty: basal state and effect of successful dilation. Lehmann KG; Gonzales E; Tri BD; Vaziri ND Am Heart J; 1999 Feb; 137(2):274-83. PubMed ID: 9924161 [TBL] [Abstract][Full Text] [Related]
40. Hemostatic risk factors in patients with coronary artery disease and type 2 diabetes - a two year follow-up of 243 patients. Jax TW; Peters AJ; Plehn G; Schoebel FC Cardiovasc Diabetol; 2009 Sep; 8():48. PubMed ID: 19735543 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]